CGON
CG Oncology, Inc.
73.40$
-5.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| -131.8% | -15,604.2% | -22,391.7% | -6,910.7% | -3,275.9% | |
| 0.1% | 7.9% | 8.3% | 2.8% | 35.8% | |
| 10.7% | 353.9% | 749.0% | 1,001.1% | 660.3% | |
| -19.0% | 2,324.1% | 1,685.8% | 255.1% | 56.3% | |
| 0.9% | 7.3% | 0.0% | 20.5% | 3.3% | |
| -0.9% | -28,980.1% | -59,409.3% | -26,406.0% | -6,084.7% | |
| 146.8% | 0.0% | -7,985.8% | -32.0% | 0.0% | |
| 149.1% | 62,666.0% | 42,645.6% | 55,160.6% | 3,801.7% | |
| 16.4% | 18,081.7% | -39,155.4% | 21,843.9% | -5,558.9% | |
| -132.8% | -15,611.5% | -22,391.7% | -6,931.3% | -3,279.2% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.